A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

Active:	Yes
Cancer Type:	Head and Neck Cancer Skin Cancer (Non-Melanoma) Unknown Primary	NCT ID:	NCT05459129
Trial Phases:	Phase I Phase II	Protocol IDs:	CO43613 (primary) NCI-2022-06114
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Hoffmann-La Roche
NCI Full Details:	http://clinicaltrials.gov/show/NCT05459129

Summary

This is a Phase Ib/II, open-label, multicenter, randomized, umbrella study in
participants with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
The study will enroll treatment-naive participants with resectable Stage III-IVA human
papillomavirus (HPV)-negative, programmed death-ligand 1 (PD-L1)-positive SCCHN with
measurable disease, as assessed by the investigator according to Response Evaluation
Criteria in Solid Tumors, Version 1.1 (RECIST v1.1) who have not received systemic
treatment for their disease.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.